158 related articles for article (PubMed ID: 25403811)
1. The characteristic structure of anti-HIV actinohivin in complex with three HMTG D1 chains of HIV-gp120.
Zhang F; Hoque MM; Jiang J; Suzuki K; Tsunoda M; Takeda Y; Ito Y; Kawai G; Tanaka H; Takénaka A
Chembiochem; 2014 Dec; 15(18):2766-73. PubMed ID: 25403811
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into the specific anti-HIV property of actinohivin: structure of its complex with the α(1-2)mannobiose moiety of gp120.
Hoque MM; Suzuki K; Tsunoda M; Jiang J; Zhang F; Takahashi A; Ohbayashi N; Zhang X; Tanaka H; Omura S; Takénaka A
Acta Crystallogr D Biol Crystallogr; 2012 Dec; 68(Pt 12):1671-9. PubMed ID: 23151632
[TBL] [Abstract][Full Text] [Related]
3. Actinohivin: specific amino acid residues essential for anti-HIV activity.
Takahashi A; Inokoshi J; Tsunoda M; Suzuki K; Takenaka A; Sekiguchi T; Omura S; Tanaka H
J Antibiot (Tokyo); 2010 Nov; 63(11):661-5. PubMed ID: 20842142
[TBL] [Abstract][Full Text] [Related]
4. Mechanism by which the lectin actinohivin blocks HIV infection of target cells.
Tanaka H; Chiba H; Inokoshi J; Kuno A; Sugai T; Takahashi A; Ito Y; Tsunoda M; Suzuki K; Takénaka A; Sekiguchi T; Umeyama H; Hirabayashi J; Omura S
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15633-8. PubMed ID: 19717426
[TBL] [Abstract][Full Text] [Related]
5. The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity.
Takahashi A; Inokoshi J; Hachiya A; Oka S; Omura S; Tanaka H
J Antibiot (Tokyo); 2011 Aug; 64(8):551-7. PubMed ID: 21694730
[TBL] [Abstract][Full Text] [Related]
6. Crystallographic study of the interaction of the anti-HIV lectin actinohivin with the α(1-2)mannobiose moiety of gp120 HMTG.
Suzuki K; Ohbayashi N; Jiang J; Zhang X; Hoque MM; Tsunoda M; Murayama K; Tanaka H; Takénaka A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Sep; 68(Pt 9):1060-3. PubMed ID: 22949194
[TBL] [Abstract][Full Text] [Related]
7. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
[TBL] [Abstract][Full Text] [Related]
8. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
[TBL] [Abstract][Full Text] [Related]
9. Peculiarity in crystal packing of anti-HIV lectin actinohivin in complex with α(1-2)mannobiose.
Suzuki K; Tsunoda M; Hoque MM; Zhang F; Jiang J; Zhang X; Ohbayashi N; Tanaka H; Takénaka A
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1818-25. PubMed ID: 23999305
[TBL] [Abstract][Full Text] [Related]
10. Essential regions for antiviral activities of actinohivin, a sugar-binding anti-human immunodeficiency virus protein from an actinomycete.
Takahashi A; Inokoshi J; Chiba H; Omura S; Tanaka H
Arch Biochem Biophys; 2005 May; 437(2):233-40. PubMed ID: 15850563
[TBL] [Abstract][Full Text] [Related]
11. A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands.
Enríquez-Navas PM; Marradi M; Padro D; Angulo J; Penadés S
Chemistry; 2011 Feb; 17(5):1547-60. PubMed ID: 21268157
[TBL] [Abstract][Full Text] [Related]
12. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity.
Shahzad-ul-Hussan S; Gustchina E; Ghirlando R; Clore GM; Bewley CA
J Biol Chem; 2011 Jun; 286(23):20788-96. PubMed ID: 21471192
[TBL] [Abstract][Full Text] [Related]
14. The mannose-specific bulb lectin from Galanthus nivalis (snowdrop) binds mono- and dimannosides at distinct sites. Structure analysis of refined complexes at 2.3 A and 3.0 A resolution.
Hester G; Wright CS
J Mol Biol; 1996 Oct; 262(4):516-31. PubMed ID: 8893860
[TBL] [Abstract][Full Text] [Related]
15. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
[TBL] [Abstract][Full Text] [Related]
16. The antiviral lectin cyanovirin-N: probing multivalency and glycan recognition through experimental and computational approaches.
Woodrum BW; Maxwell JD; Bolia A; Ozkan SB; Ghirlanda G
Biochem Soc Trans; 2013 Oct; 41(5):1170-6. PubMed ID: 24059504
[TBL] [Abstract][Full Text] [Related]
17. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis.
Balzarini J; Van Laethem K; Hatse S; Froeyen M; Van Damme E; Bolmstedt A; Peumans W; De Clercq E; Schols D
Mol Pharmacol; 2005 May; 67(5):1556-65. PubMed ID: 15718224
[TBL] [Abstract][Full Text] [Related]
18. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
[TBL] [Abstract][Full Text] [Related]
19. A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity.
Fromme R; Katiliene Z; Giomarelli B; Bogani F; Mc Mahon J; Mori T; Fromme P; Ghirlanda G
Biochemistry; 2007 Aug; 46(32):9199-207. PubMed ID: 17636873
[TBL] [Abstract][Full Text] [Related]
20. Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
Andrianov AM; Anishchenko IV
J Biomol Struct Dyn; 2009 Oct; 27(2):179-93. PubMed ID: 19583444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
